Netscribes' latest market research report titled Hospital Market in India 2014 captures the largest segment of the overall domestic healthcare market. The emerging Indian economy is witnessing rapid expansion of the hospital market. The growing burden of disease, along with unhealthy lifestyles, aging population, growing affordability and widespread health insurance penetration comprise some of the key factors propelling the hospital sector. The market is clearly segmented into public and private sectors wherein the public sector caters to a larger population base that is unable to afford the relatively expensive private hospital services. The private sector is diverting its business progressively from metro city markets and is focusing on capturing market share in tier-II and tier-III cities with the introduction of hospital chains and specialty clinics aimed at attracting the masses towards quality healthcare services.
The Indian government's awareness about the large gap in the delivery of healthcare services is seeing both direct and indirect initiatives towards raising the level of service availability. Higher budgetary allocations, financial incentives and public private partnerships are some of the methodologies being adopted to bridge this gap. A number of non-healthcare related business houses are also venturing into the healthcare delivery space due to the immense growth opportunities that exist within the sector, resulting in greater competitiveness and betterment of service delivery on the part of the market players.

Slide 1: Executive Summary

Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2010-11 - 2013-14), Inflation Rate: Monthly (Jul 2013 - Dec 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 - Jul 2013), Exchange Rate: Half Yearly (Aug 2013 - Jan 2014)
Slide 4: Lending Rate: Annual (2008-09 - 2011-12), Trade Balance: Annual (2009-10 - 2012-13), FDI: Annual (2009-10 - 2012-13)

Indian Healthcare Scenario
Slide 5-7: Indian Healthcare Industry Overview

Introduction
Slide 8-9: Hospital - Classification of Hospitals

Market Overview
Slide 10: Hospital - Market Overview, Market Size & Growth (Value-Wise; 2012 - 2018e)
Slide 11: Public-Private Hospital Distribution Profile in India

Drivers & Challenges
Slide 12: Drivers and Challenges - Summary
Slide 13-21: Drivers
Slide 22-25: Challenges

IT Adoption
Slide 26: IT Adoption in Indian Healthcare
Slide 27: Healthcare IT Products

Role of Government
Slide 28: Role of Government - Summary
Slide 29-32: Role of Government

Trends
Slide 33: Trends - Summary
Slide 34-36: Major Trends in the Market

Key Initiatives
Slide 37: Key Initiatives
Slide 38-40: Key Initiatives

Competitive Landscape
Slide 44: Porter's Five Forces Analysis
Slide 45-49: Competitive Benchmarking (FY 2013)
Slide 50-57: Major Public Players
Slide 58-100: Major Private Players
Slide 101: Market Entrants

Trade Fairs & Events
Slide 102: Trade Fairs & Events

Recent Transactions
Slide 103-104: Recent Transactions

Strategic Insights
Slide 105-106: Strategic Insights

Appendix
Slide 107: Key Ratios Description
Slide 108: Sources of Information

Hospital Supplies and Consumable Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Hospital Supplies and Consumable Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...

Hospital Treatment Fee Evaluation Services Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Hospital Treatment Fee Evaluation Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...

Modular Hospital Field Solutions Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Modular Hospital Field Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...

Hospital Location Management Software Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Hospital Location Management Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...

Asia Pacific Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Idiopathic Pulmonary Fibrosis (IPF) Market is expected to witness substantial growth from 2024 to 2034, driven by the rising prevalence of IPF, advancements in drug development, and an increasing focus on early diagnosis and treatment. The market is proj...

Europe Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Idiopathic Pulmonary Fibrosis (IPF) Market is expected to witness significant growth between 2024 and 2034, driven by the increasing prevalence of IPF, advancements in drug development, and improved diagnostic methods. The market is projected to reach USD XX.X...

North America Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The North America Idiopathic Pulmonary Fibrosis (IPF) Market is projected to experience robust growth from 2024 to 2034, driven by advancements in therapeutic options, increasing prevalence of IPF, and a growing emphasis on early diagnosis and treatment. The market size ...

Global Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Global Idiopathic Pulmonary Fibrosis (IPF) Market is poised to experience significant growth between 2024 and 2034, driven by advancements in drug development, increasing prevalence of IPF, and heightened awareness about the disease. Valued at USD XX.XX billion in 20...

Asia Pacific Neurofibromatosis Treatment Market Size, Share, Trends & Analysis by Disease Type (Neurofibromatosis 1 (NF1), Neurofibromatosis 2 (NF2), Schwannomatosis), by Treatment (Medications, Surgery, Radiation Therapy, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Neurofibromatosis Treatment Market is anticipated to witness substantial growth from 2024 to 2034, driven by increasing awareness and diagnosis of neurofibromatosis (NF), advancements in treatment options, and a growing patient population. The market is ...

Europe Neurofibromatosis Treatment Market Size, Share, Trends & Analysis by Disease Type (Neurofibromatosis 1 (NF1), Neurofibromatosis 2 (NF2), Schwannomatosis), by Treatment (Medications, Surgery, Radiation Therapy, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Neurofibromatosis Treatment Market is projected to experience substantial growth from 2024 to 2034, driven by advancements in medical treatments, increasing prevalence of neurofibromatosis disorders, and rising awareness about these conditions. The market is e...